In a significant boost to the biopharma sector, the Indian Council of Medical Research (ICMR) has issued an Expressions of Interest (EoI) to license its indigenous malaria vaccine, AdFalciVax. The vaccine targets Plasmodium falciparum...
In a significant advancement in areas of adult and geriatric care, Akums Drugs & Pharmaceuticals Ltd. has released India's first high-strength paracetamol oral suspension at 500mg/5ml, establishing a new model for the country's pharmaceutical...
.jpg)
Arushi Jain, a corporate growth strategist in the pharmaceutical sector, brings over a decade of cross-functional experience. She specializes in operational excellence, risk advisory, and scaling healthcare ventures. With expertise spanning internal
Biocon Biologics has announced US FDA approval for Kirsty (Insulin Aspart-xjhz, 100 units/mL). It's an extremely important development as Kirsty is the first and only interchangeable biosimilar to NovoLog, a rapid-acting insulin brand...
The InfinityLab Pro iQ Series mass detectors were launched by Agilent Technologies in India. The series is designed for next-generation liquid chromatography-mass detection (LC-MS) and aims to improve how impurities, trace contaminants, and complex
In a landmark deal that will transform diabetes care in India, Emcure Pharmaceuticals has entered an exclusive partnership with Sanofi India to sell and distribute some of Sanofi's most established oral anti-diabetic (OAD) products in the country...
An appeal has been made to the Prime Minister by Sumanata Kumar Tiwari, the joint director-cum-drug controller of Jharkhand, for a significant overhaul of the current regulatory framework to combat the escalating menace of counterfeit medicines
.png)
PharmaJet has signed a strategic Memorandum of Understanding with Egypt’s Unified Procurement Authority (UPA) and leading pharmaceutical company EVA Pharma to enable introduction of needle-free vaccine delivery as part of their routine...
India’s pharmaceutical sector is focused on a major goal of increasing exports to USD 1 trillion, and biosimilars are emerging as the cornerstone of this growth. Currently valued at USD 50–55 billion, pharmaceutical exports from India are expected...
In a bold strategic shift, Wockhardt has divested its U.S. generics business to focus on high-value, innovative therapies, including novel antibiotics and biologics. The company announced the voluntary liquidation of Wockhardt USA LLC and Morton...
.jpg)
.jpg)
, CDSCO.jpg)